Exponent (NASDAQ:EXPO) VP Bradley James Sells 2,000 Shares of Stock

Exponent, Inc. (NASDAQ:EXPO) VP Bradley James sold 2,000 shares of Exponent stock in a transaction on Tuesday, May 26th. The stock was sold at an average price of $57.47, for a total transaction of $114,940.00. Following the transaction, the vice president directly owned 1,105 shares of the company’s stock, valued at approximately $63,504.35. This trade represents a 64.41% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Exponent Price Performance

EXPO stock opened at $57.08 on Thursday. The company has a fifty day moving average price of $63.67 and a two-hundred day moving average price of $69.06. Exponent, Inc. has a one year low of $51.91 and a one year high of $81.95. The stock has a market cap of $2.77 billion, a price-to-earnings ratio of 26.55 and a beta of 0.78.

Exponent (NASDAQ:EXPO) last released its quarterly earnings data on Thursday, April 30th. The business services provider reported $0.59 EPS for the quarter, topping analysts’ consensus estimates of $0.56 by $0.03. Exponent had a net margin of 18.07% and a return on equity of 27.94%. The firm had revenue of $166.30 million during the quarter, compared to analysts’ expectations of $149.53 million. During the same period in the previous year, the business posted $0.52 earnings per share. The company’s revenue for the quarter was up 14.3% compared to the same quarter last year. Research analysts anticipate that Exponent, Inc. will post 2.28 EPS for the current fiscal year.

Exponent Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, June 18th. Shareholders of record on Friday, June 5th will be given a dividend of $0.31 per share. This represents a $1.24 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date of this dividend is Friday, June 5th. Exponent’s payout ratio is 57.67%.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on the stock. UBS Group reduced their price objective on shares of Exponent from $85.00 to $75.00 and set a “neutral” rating for the company in a research report on Friday, May 1st. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Exponent in a research report on Tuesday, April 21st. Finally, JPMorgan Chase & Co. reduced their price objective on shares of Exponent from $95.00 to $80.00 and set an “overweight” rating for the company in a research report on Friday, May 15th. Two investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $77.50.

Institutional Investors Weigh In On Exponent

Institutional investors have recently modified their holdings of the business. Bell Investment Advisors Inc boosted its position in shares of Exponent by 423.6% in the first quarter. Bell Investment Advisors Inc now owns 377 shares of the business services provider’s stock valued at $25,000 after acquiring an additional 305 shares during the period. Hantz Financial Services Inc. boosted its position in shares of Exponent by 97.0% in the third quarter. Hantz Financial Services Inc. now owns 396 shares of the business services provider’s stock valued at $28,000 after acquiring an additional 195 shares during the period. Aster Capital Management DIFC Ltd bought a new stake in shares of Exponent in the third quarter valued at about $33,000. Allworth Financial LP boosted its position in shares of Exponent by 86.1% in the fourth quarter. Allworth Financial LP now owns 469 shares of the business services provider’s stock valued at $33,000 after acquiring an additional 217 shares during the period. Finally, Winnow Wealth LLC bought a new stake in shares of Exponent in the third quarter valued at about $34,000. Institutional investors own 92.37% of the company’s stock.

Exponent Company Profile

Exponent, Inc (NASDAQ: EXPO) is an engineering and scientific consulting firm that offers multidisciplinary analysis and advisory services to clients across a range of industries. The company’s expertise spans mechanical, materials and corrosion engineering, civil and structural engineering, electrical engineering, industrial hygiene, toxicology and health sciences, and failure analysis. Exponent provides support for product design, performance evaluation, litigation consulting, and regulatory compliance, helping manufacturers, insurers, law firms and government agencies address complex technical challenges.

Founded in 1967 in Menlo Park, California, Exponent has grown from a small failure-analysis laboratory into a global consulting practice.